Evidence map›Paper›PMID 37433374›Full record

ArticleInternational journal of radiation oncology, biology, physics2023

Gastrointestinal Toxicity Prediction Not Influenced by Rectal Contour or Dose-Volume Histogram Definition.

Douglas H Brand, Sarah C Brüningk, Anna Wilkins, Olivia Naismith, Annie Gao, Isabel Syndikus, David P Dearnaley, Emma Hall, Nicholas van As, Alison C Tree and 1 more

Open access · hybridAbstract read
In one paragraph

Article in International journal of radiation oncology, biology, physics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Douglas H BrandDivision of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom; Department of Medical Physics and Biomedical Engineering, University College London, London, United Kingdom. Electronic address: douglas.brand@icr.ac.uk.
Sarah C BrüningkDepartment of Health Science and Technology, ETH Zurich, Basel, Switzerland; Swiss Institute for Bioinformatics (SIB), Lausanne, Switzerland.
Anna WilkinsDivision of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom; Urology Unit.
Olivia NaismithRadiotherapy Trials QA Group (RTTQA), Royal Marsden NHS Foundation Trust, London, United Kingdom.
Annie GaoDivision of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom; Urology Unit.
Isabel SyndikusRadiotherapy Department, Clatterbridge Cancer Centre, Liverpool, United Kingdom.
David P DearnaleyDivision of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom; Urology Unit.
Emma HallClinical Trials and Statistics Unit, The Institute of Cancer Research, London, United Kingdom.
Nicholas van AsDivision of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom; Urology Unit.
Alison C TreeDivision of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom; Urology Unit.
Sarah GullifordDepartment of Medical Physics and Biomedical Engineering, University College London, London, United Kingdom; Department of Radiotherapy Physics, University College London Hospitals NHS Foundation Trust, London, United Kingdom.
Royal Marsden NHS Foundation Trust · GBInstitute of Cancer Research · GBClatterbridge Cancer Centre NHS Foundation Trust · GBSIB Swiss Institute of Bioinformatics · CHUniversity College London Hospitals NHS Foundation Trust · GB

Funding

Cancer Research UK 25351
6 · The paper itself

Abstract

purposeRectal dose delivered during prostate radiation therapy is associated with gastrointestinal toxicity. Treatment plans are commonly optimized using rectal dose-volume constraints, often whole-rectum relative-volumes (%). We investigated whether improved rectal contouring, use of absolute-volumes (cc), or rectal truncation might improve toxicity prediction. METHODS AND MATERIALS: Patients from the CHHiP trial (receiving 74 Gy/37 fractions [Fr] vs 60 Gy/20 Fr vs 57 Gy/19 Fr) were included if radiation therapy plans were available (2350/3216 patients), plus toxicity data for relevant analyses (2170/3216 patients). Whole solid rectum relative-volumes (%) dose-volume-histogram (DVH), as submitted by treating center (original contour), was assumed standard-of-care. Three investigational rectal DVHs were generated: (1) reviewed contour per CHHiP protocol; (2) original contour absolute volumes (cc); and (3) truncated original contour (2 versions; ±0 and ±2 cm from planning target volume [PTV]). Dose levels of interest (V30, 40, 50, 60, 70, 74 Gy) in 74 Gy arm were converted by equivalent-dose-in-2 Gy-Fr (EQD2

resultsThe alternative dose/volume parameters were compared with the original relative-volume (%) DVH of the whole rectal contour, itself fitted as a weak predictor of toxicity (AUC range, 0.57-0.65 across the 8 toxicity measures). There were no significant differences in toxicity prediction for: (1) original versus reviewed rectal contours (AUCs, 0.57-0.66; P = .21-.98); (2) relative- versus absolute-volumes (AUCs, 0.56-0.63; P = .07-.91); and (3) whole-rectum versus truncation at PTV ± 2 cm (AUCs, 0.57-0.65; P = .05-.99) or PTV ± 0 cm (AUCs, 0.57-0.66; P = .27-.98).

conclusionsWe used whole-rectum relative-volume DVH, submitted by the treating center, as the standard-of-care dosimetric predictor for rectal toxicity. There were no statistically significant differences in prediction performance when using central rectal contour review, with the use of absolute-volume dosimetry, or with rectal truncation relative to PTV. Whole-rectum relative-volumes were not improved upon for toxicity prediction and should remain standard-of-care.

Indexed as

Prostatic NeoplasmsRadiation InjuriesRadiotherapy, ConformalHumansMaleRadiotherapy DosageRectum

Identifiers

PMID37433374
PMCPMC10680426
OpenAlexW4383998376

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.